+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glucagon Like Peptide 1 Agonist"

Prediabetes Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Prediabetes Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Type 2 Diabetes Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034) - Product Thumbnail Image

Type 2 Diabetes Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034 - Product Thumbnail Image

Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034

  • Report
  • May 2025
  • 300 Pages
  • Global
From
Glucagon-Like Peptide 1 Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Glucagon-Like Peptide 1 Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • October 2025
  • 160 Pages
  • Global
From
Peptide Based Metabolic Disorder Therapeutic Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Peptide Based Metabolic Disorder Therapeutic Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • December 2025
  • 150 Pages
  • Global
From
Metabolism Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Metabolism Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • October 2025
  • 150 Pages
  • Global
From
Sulfonylurea Hypoglycemic Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Sulfonylurea Hypoglycemic Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • July 2025
  • 150 Pages
  • Global
From
Linagliptin DPP-4 Inhibitor Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Linagliptin DPP-4 Inhibitor Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Type 2 Diabete Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Type 2 Diabete Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • September 2025
  • 142 Pages
  • Global
From
Antidiabetics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Antidiabetics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • May 2025
  • 90 Pages
  • Global
From
Semaglutide Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Semaglutide Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • May 2025
  • 81 Pages
  • Global
From
Metabolic Syndrome Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Metabolic Syndrome Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

  • Report
  • April 2025
  • 90 Pages
  • Global
From
SGLT2 Inhibitors Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

SGLT2 Inhibitors Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • September 2025
  • 87 Pages
  • Global
From
DPP-4 Inhibitor Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

DPP-4 Inhibitor Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • August 2025
  • 98 Pages
  • Global
From
GLP-1 Agonists Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology - Product Thumbnail Image

GLP-1 Agonists Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology

  • Report
  • March 2025
  • 83 Pages
  • Global
From
Metabolic Dysfunction-Associated Steatohepatitis (MASH): Seven-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Metabolic Dysfunction-Associated Steatohepatitis (MASH): Seven-Market Drug Forecast and Market Analysis - Update

  • Report
  • June 2025
  • 131 Pages
  • Global
From
Semaglutide Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Semaglutide Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • November 2025
  • 160 Pages
  • Global
From
Antidiabetics Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Antidiabetics Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • November 2025
  • 160 Pages
  • Global
From
Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update - Product Thumbnail Image

Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update

  • Report
  • March 2025
  • 1400 Pages
  • Global
From
Diabetes Drug Market Overview, 2025-30 - Product Thumbnail Image

Diabetes Drug Market Overview, 2025-30

  • Report
  • June 2025
  • 109 Pages
  • Global
From
Loading Indicator

The Glucagon Like Peptide 1 Agonist (GLP-1) market is a subset of the larger diabetes drugs market. GLP-1 agonists are a class of drugs used to treat type 2 diabetes, and are designed to mimic the effects of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 agonists work by stimulating the release of insulin, reducing the amount of glucose in the blood, and slowing the rate of gastric emptying. GLP-1 agonists are typically administered via injection, and are used in combination with other diabetes medications. The GLP-1 agonist market is highly competitive, with a number of major pharmaceutical companies offering products. These include Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, and Boehringer Ingelheim. Show Less Read more